Systemic therapy, survival and end-of-life costs for metastatic triple-negative breast cancer: retrospective SEER-Medicare study of women age ≥65 years

Role of Immunotherapy in Triple-Negative Breast Cancer

(2020) Tanya E. Keenan et al.   Journal of the National Comprehensive Cancer Network

Immunotherapy and targeted therapy combinations in metastatic breast cancer

(2019) Francisco J Esteva et al.   LANCET ONCOLOGY

Breast Cancer Treatment

(2019) Adrienne G. Waks et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Overall survival, costs and healthcare resource use by number of regimens received in elderly patients with newly diagnosed metastatic triple-negative breast cancer

(2019) Abdalla Aly et al.   Future Oncology

Immunotherapy in Older Adults with Cancer

(2019) Richard Curtis Godby et al.   Current Oncology Reports

Update on triple‐negative breast cancer disparities for the United States: A population‐based study from the United States Cancer Statistics database, 2010 through 2014

(2019) Lia C. Scott et al.   CANCER

Breast cancer statistics, 2019

(2019) Carol E. DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States

(2018) Kendra L. Schwartz et al.   CANCER

Differences in Breast Cancer Survival by Molecular Subtypes in the United States

(2018) Nadia Howlader et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Using oncology real-world evidence for quality improvement and discovery: the case for ASCO's CancerLinQ

(2018) Robert S Miller et al.   Future Oncology

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

(2018) Peter Schmid et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immune checkpoint inhibitors and elderly people: A review

(2017) Amaury Daste et al.   EUROPEAN JOURNAL OF CANCER

Research needs in breast cancer

(2016) F. Cardoso et al.   ANNALS OF ONCOLOGY

Comparison of SEER Treatment Data With Medicare Claims

(2016) Anne-Michelle Noone et al.   MEDICAL CARE

Receipt of Chemotherapy Among Medicare Patients With Cancer by Type of Supplemental Insurance

(2015) Joan L. Warren et al.   JOURNAL OF CLINICAL ONCOLOGY

Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario

(2014) M. Bonotto et al.   ONCOLOGIST

Sensitivity of Medicare Claims Data for Measuring Use of Standard Multiagent Chemotherapy Regimens

(2012) Elizabeth B. Lamont et al.   MEDICAL CARE